[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AR105646A1 - Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida - Google Patents

Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida

Info

Publication number
AR105646A1
AR105646A1 ARP160102430A ARP160102430A AR105646A1 AR 105646 A1 AR105646 A1 AR 105646A1 AR P160102430 A ARP160102430 A AR P160102430A AR P160102430 A ARP160102430 A AR P160102430A AR 105646 A1 AR105646 A1 AR 105646A1
Authority
AR
Argentina
Prior art keywords
alkyl
phosphonooxy
phenyl
formula
group
Prior art date
Application number
ARP160102430A
Other languages
English (en)
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Publication of AR105646A1 publication Critical patent/AR105646A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Compuestos derivados de pirrolo[1,2-c]imidazol útiles como agentes antibacterianos, particularmente para el tratamiento de infecciones provocadas por bacterias Gram-negativas. Reivindicación 1: Un compuesto de la fórmula (1) en donde M es uno de los grupos de fórmula (2), (3) y (4) y cualquier R¹ representa H y, cuando M es el compuesto de fórmula (2), R² representa SO₃H, fosfonooximetilo o el grupo de fórmula (5) en donde R²A representa alquil C₁₋₄aminoalquilo C₁₋₄, [dialquil C₂₋₄amino]metilo, {(metil)[alquil C₂₋₄]amino}metilo, [dialquil C₁₋₄amino]alquilo C₂₋₄, morfolin-4-il-alquilo C₁₋₄, fosfonooxialquilo C₁₋₄, fosfonooximetoxi, 2-(fosfonooxi-alquil C₁₋₄)-fenilo, (2-(fosfonooxi)-fenil)-alquilo C₁₋₄ o [2-(fosfonooxi-alquil C₁₋₄)-fenil]-alquilo C₁₋₄, o, cuando M es el compuesto de fórmula (3) ó (4), R² representa PO₃H₂, SO₃H, fosfonooximetilo o el grupo de fórmula (6) en donde R²BC representa alquil C₁₋₄aminoalquilo C₁₋₄, [dialquil C₁₋₄amino]alquilo C₁₋₄, morfolin-4-il-alquilo C₁₋₄, fosfonooxialquilo C₁₋₄, fosfonooximetoxi, 2-(fosfonooxi-alquil C₁₋₄)-fenilo, (2-(fosfonooxi)-fenil)-alquilo C₁₋₄ o [2-(fosfonooxi-alquil C₁₋₄)-fenil]-alquilo C₁₋₄, o R² representa H y R¹ representa PO₃H₂, SO₃H, fosfonooximetilo o el grupo de fórmula (7) en donde R¹A representa alquil C₁₋₄aminoalquilo C₁₋₄, [dialquil C₁₋₄amino]alquilo C₁₋₄, morfolin-4-il-alquilo C₁₋₄, fosfonooxialquilo C₁₋₄, fosfonooximetoxi, 2-(fosfonooxi-alquil C₁₋₄)-fenilo, (2-(fosfonooxi)-fenil)-alquilo C₁₋₄ o [2-(fosfonooxi-alquil C₁₋₄)-fenil]-alquilo C₁₋₄; y se entiende que la molécula es siempre de tal manera que su grupo R² se encuentra unido al átomo de oxígeno de su grupo de fórmula (2), (3) y (4); o una sal de este compuesto.
ARP160102430A 2015-08-11 2016-08-08 Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida AR105646A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP2015068450 2015-08-11
EP2015070054 2015-09-02

Publications (1)

Publication Number Publication Date
AR105646A1 true AR105646A1 (es) 2017-10-25

Family

ID=56684659

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160102430A AR105646A1 (es) 2015-08-11 2016-08-08 Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida

Country Status (16)

Country Link
US (1) US10441576B2 (es)
EP (1) EP3334737B1 (es)
JP (1) JP2018526354A (es)
KR (1) KR20180037051A (es)
CN (1) CN108026100B (es)
AR (1) AR105646A1 (es)
AU (1) AU2016305278A1 (es)
CA (1) CA2988660A1 (es)
CL (1) CL2018000356A1 (es)
EA (1) EA201890476A1 (es)
ES (1) ES2760955T3 (es)
IL (1) IL257413A (es)
MX (1) MX2018001725A (es)
PH (1) PH12018500301A1 (es)
TW (1) TW201716411A (es)
WO (1) WO2017025562A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR099612A1 (es) 2014-03-04 2016-08-03 Actelion Pharmaceuticals Ltd Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona
JP6532599B2 (ja) 2015-09-02 2019-06-19 グラクソスミスクライン、インテレクチュアル、プロパティー、（ナンバー２）、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ （Ｎｏ．２） Ｌｉｍｉｔｅｄ ブロモドメイン阻害薬としての使用のためのピリジノンジカルボキサミド
AR105889A1 (es) 2015-09-03 2017-11-22 Actelion Pharmaceuticals Ltd Compuestos antibacterianos 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituidos
TW201840569A (zh) * 2017-03-01 2018-11-16 瑞士商愛杜西亞製藥有限公司 (2r)-n-羥基-4-(6-((1-(2-羥基乙基)氮雜環丁烷-3-基)丁-1,3-二炔-1-基)-3-氧基-1h-吡咯并[1,2-c]咪唑-2(3h)-基)-2-甲基-2-(甲磺醯基)丁醯胺之結晶形式
WO2019038362A1 (en) * 2017-08-24 2019-02-28 Idorsia Pharmaceuticals Ltd ANTIBACTERIAL PYRROLOIMIDAZOLONES
WO2019086452A1 (en) * 2017-10-31 2019-05-09 Idorsia Pharmaceuticals Ltd Antibacterial heteroaromatic compounds

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04008893A (es) 2002-03-13 2005-06-20 Array Biopharma Inc Derivados de bencimidazol n3 alquilados como inhibidores de mek.
UA80500C2 (en) 2003-10-17 2007-09-25 Basf Ag Fungicidal mixture and agent for controlling rice pathogens, containing triazolopyrimidine derivative and metalaxyl-m, method for controlling rice pathogens and sowing material
CA2735929C (en) 2008-09-19 2013-12-17 Pfizer Inc. Hydroxamic acid derivatives useful as antibacterial agents
DE102008044132A1 (de) 2008-11-27 2010-06-02 BSH Bosch und Siemens Hausgeräte GmbH Kältegerät mit zweiseitig anschlagbarer Tür
CA2774250C (en) 2009-10-13 2013-12-17 Pfizer Inc. C-linked hydroxamic acid derivatives useful as antibacterial agents
ES2525820T3 (es) 2009-12-16 2014-12-30 Pfizer Inc. Derivados del ácido hidroxámico N-enlazados útiles como agentes antibacterianos
KR101593288B1 (ko) * 2011-03-07 2016-02-11 화이자 인코포레이티드 항균제로서 유용한 플루오로-피리디논 유도체
KR20130140868A (ko) 2011-04-08 2013-12-24 화이자 인코포레이티드 항세균제로서 유용한 이속사졸 유도체
SG193458A1 (en) * 2011-04-08 2013-10-30 Pfizer Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents
EP2847168A1 (en) * 2012-05-10 2015-03-18 Achaogen, Inc. Antibacterial agents
GB201209138D0 (en) * 2012-05-24 2012-07-04 Ono Pharmaceutical Co Compounds
CN104684898A (zh) * 2012-09-26 2015-06-03 佐蒂斯有限责任公司 酰胺醇类抗细菌剂
AR097617A1 (es) 2013-09-13 2016-04-06 Actelion Pharmaceuticals Ltd Derivados antibacterianos del 2h-indazol
WO2015066413A1 (en) * 2013-11-01 2015-05-07 Novartis Ag Oxazolidinone hydroxamic acid compounds for the treatment of bacterial infections
AR100032A1 (es) 2013-12-19 2016-09-07 Actelion Pharmaceuticals Ltd Derivados antibacterianos de 1h-indazol y 1h-indol
AR099612A1 (es) 2014-03-04 2016-08-03 Actelion Pharmaceuticals Ltd Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona
EA201692305A1 (ru) * 2014-05-16 2017-05-31 Актелион Фармасьютиклз Лтд. Антибактериальные хиназолин-4(3н)-оновые производные
EA031534B1 (ru) 2014-11-19 2019-01-31 Идорсиа Фармасьютиклз Лтд Антибактериальные бензотиазольные производные
MA42679A (fr) 2015-08-28 2018-07-04 Idorsia Pharmaceuticals Ltd Dérivés de pyrrolidin-2-one annelés antibactériens
AR105848A1 (es) 2015-08-31 2017-11-15 Actelion Pharmaceuticals Ltd Derivados heterocíclicos antibacterianos
AR105889A1 (es) 2015-09-03 2017-11-22 Actelion Pharmaceuticals Ltd Compuestos antibacterianos 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituidos
CA3007653A1 (en) 2015-12-08 2017-06-15 Glaxosmithkline Intellectual Property Development Limited Substituted benzazinones as antibacterial compounds
EP3458453A1 (en) 2016-05-17 2019-03-27 Idorsia Pharmaceuticals Ltd 6-(buta-1,3-diyn-1-yl)benzo[d]thiazole derivatives

Also Published As

Publication number Publication date
ES2760955T3 (es) 2020-05-18
US10441576B2 (en) 2019-10-15
PH12018500301A1 (en) 2018-08-29
JP2018526354A (ja) 2018-09-13
CL2018000356A1 (es) 2018-07-13
CN108026100A (zh) 2018-05-11
WO2017025562A1 (en) 2017-02-16
EP3334737A1 (en) 2018-06-20
AU2016305278A1 (en) 2018-03-29
KR20180037051A (ko) 2018-04-10
EP3334737B1 (en) 2019-10-09
US20180235938A1 (en) 2018-08-23
MX2018001725A (es) 2018-05-11
EA201890476A1 (ru) 2018-08-31
CA2988660A1 (en) 2017-02-16
IL257413A (en) 2018-04-30
CN108026100B (zh) 2020-09-18
TW201716411A (zh) 2017-05-16

Similar Documents

Publication Publication Date Title
AR105646A1 (es) Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida
PH12016502154A1 (en) Pyridazonine herbicides
PE20170206A1 (es) Inhibidores espirociclicos sustituidos de la autotaxina
BR112017006253A2 (pt) novos compostos
EA201400230A1 (ru) Фунгицидные замещенные 1-{2-[2-галоген-4-(4-галогенфенокси)фенил]-2-этоксиэтил}-1н-[1,2,4]триазольные соединения
CR20130333A (es) Compuestos indol o análogos de los mismos útiles en el tratamiento de la degeneración macular relacionada con la edad (dmae)
UY36838A (es) Compuestos heterocíclicos moduladores de la señalización de tnf alfa y composiciones farmacéuticas que los contienen
AR101815A1 (es) Compuestos y composiciones como inhibidores de quinasa
AR097082A1 (es) Compuestos terapéuticamente activos y sus métodos de uso
CR20160478A (es) Composición de control de enfermedades de plantas y método para controlar enfermedades de plantas mediante su aplicación
RS54730B1 (sr) Inhibitori beta sekretaze
AR084011A1 (es) Compuestos nitrogenados heterociclicos utiles para el tratamiento de infecciones por el virus sincitial respiratorio (rsv), proceso para prepararlos y composiciones farmaceuticas que los contienen
AR077080A1 (es) Compuestos de 2,3-dihidro-1h-indeno
EA201791353A1 (ru) СОЕДИНЕНИЯ ИЗОКСАЗОЛГИДРОКСАМИНОВОЙ КИСЛОТЫ В КАЧЕСТВЕ ИНГИБИТОРОВ LpxC
BR112017006240A2 (pt) novos compostos
AR106070A1 (es) Benzamidas sustituidas con isoxazolina como insecticidas
CO2019004978A2 (es) Compuestos terapéuticos y métodos para utilizarlos
AR101201A1 (es) Derivados de fenil-piridazina-dionas benciloxi sustituidos y fenil-piridazinona benciloxi sustituidos como herbicidas
AR090086A1 (es) COMPUESTO DE 1H-INDAZOL-3-CARBOXAMIDA COMO INHIBIDORES DE LA GLUCOGENO SINTASA CINASA 3 b
PE20170439A1 (es) Derivados de bis(aril)catecol como herbicidas
AR085088A1 (es) Inhibidores de histona desacetilasa y composiciones farmaceuticas que los contienen
AR114309A1 (es) Compuestos antibacterianos, composiciones de los mismos, y métodos que utilizan los mismos
AR090376A1 (es) Compuestos herbicidas
PH12019500589A1 (en) Novel mesoionic insecticidal compound
AU2015309863A8 (en) Azaindole derivative having AMPK-activating effect

Legal Events

Date Code Title Description
FB Suspension of granting procedure